Stay updated on Immunogenic Nivolumab + Ipilimumab in Prostate Cancer Clinical Trial

Sign up to get notified when there's something new on the Immunogenic Nivolumab + Ipilimumab in Prostate Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immunogenic Nivolumab + Ipilimumab in Prostate Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Added a new MedlinePlus Genetics topic: Prostate cancer.
    Difference
    0.3%
    Check dated 2025-10-12T14:16:47.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    Core content updated with a government funding notice and updated operating-status guidance; version updated from v3.1.0 to v3.2.0.
    Difference
    4%
    Check dated 2025-10-05T09:29:16.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    New version released (v3.1.0) with removal of a MedlinePlus Genetics topic on Prostate cancer; previous version tag v3.0.2 is no longer referenced.
    Difference
    0.4%
    Check dated 2025-09-28T03:09:28.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Added a new MedlinePlus Genetics topic covering Prostate cancer, expanding the page's informational scope.
    Difference
    0.3%
    Check dated 2025-09-20T22:05:37.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The page version was updated from v3.0.1 to v3.0.2; a 'Back to Top' link was removed, with no substantive content changes.
    Difference
    0.2%
    Check dated 2025-09-13T17:10:58.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-06T14:35:59.000Z thumbnail image

Stay in the know with updates to Immunogenic Nivolumab + Ipilimumab in Prostate Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immunogenic Nivolumab + Ipilimumab in Prostate Cancer Clinical Trial page.